Dexcom, Livongo partner on glucose monitoring

By LabPulse.com staff writers

January 13, 2020 -- Dexcom is set to synchronize data collected using its G6 continuous glucose monitoring (CGM) product into Livongo's applied health signals platform, per an agreement announced on January 13, the first day of the annual J.P. Morgan Healthcare Conference in San Francisco.

The Dexcom G6 CGM system relies on a slim, water-resistant sensor to measure glucose levels beneath the skin of people with diabetes and send the data wirelessly to a server every five minutes. Integrating the CGM data into the Livongo platform will give users access to their personal glucose, blood pressure, and weight data, as well as an analysis of these data based on a combination of clinical expertise and data science, according to the companies.

Through the tie-up, Dexcom and Livongo customers will also get around-the-clock health support.

One Drop app predicts blood sugar up to 2 hours in advance
Digital diabetes therapeutics company One Drop said it has developed an artificial intelligence application that can predict blood sugar levels up to...
Dexcom set to launch new clinic-owned continuous glucose sensors
Dexcom has obtained U.S. Food and Drug Administration clearance for its new G6 Pro continuous glucose monitoring product for clinics. It plans to begin...
Random blood glucose tests poised for diabetes screening
A retrospective study of almost 1 million U.S. veterans shows the potential for population-wide random plasma glucose testing for large-scale screening,...
FDA brings glucose meter problems out into the open
The U.S. Food and Drug Administration's (FDA) just-released data from its now defunct Alternative Summary Reporting program shed light on millions...
Abbott launches rapid point-of-care blood glucose test
Abbott has launched its Afinion hemoglobin A1c Dx test for use in diagnosing diabetes and monitoring blood glucose in point-of-care settings.

Copyright © 2020 LabPulse.com

Last Updated np 1/13/2020 2:16:21 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email